Buyback programme: transactions between 6&14 Oct

RNS Number : 2677P
Banco Santander S.A.
15 October 2021
 

Banco Santander, S.A. , in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

 

Reference is made to our notice of inside information of 6 October, 2021 (official registry number 1086), relating to the buyback programme of own shares (the "Buy-back Programme") approved by the Board of Directors of Banco Santander, S.A. Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, Banco Santander, S.A. informs -on the basis of the information received from Morgan Stanley Europe SE as intermediary in charge of executing the Buy-back Programme- that it has carried out the following transactions over its own shares between 6 October and 14 October, 2021 (both included):

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

06/10/2021

SAN.MC

Purchase

XMAD

5,799,954

€3.2229

07/10/2021

SAN.MC

Purchase

XMAD

5,772,396

€3.3114

08/10/2021

SAN.MC

Purchase

XMAD

5,229,125

€3.3562

11/10/2021

SAN.MC

Purchase

XMAD

5,507,157

€3.3555

12/10/2021

SAN.MC

Purchase

XMAD

5,909,094

€3.3490

13/10/2021

SAN.MC

Purchase

XMAD

6,090,491

€3.3213

14/10/2021

SAN.MC

Purchase

XMAD

6,983,255

€3.3157

TOTAL

41,291,472


 

Issuer name : Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument : ordinary shares - Code ISIN ES0113900J37

 

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 15 October 2021

 



 

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 6 October and 14 October 2021 (both included)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGQUUUPGGPA
UK 100

Latest directors dealings